These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 3113256)
21. The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy. Kaplan G; Britton WJ; Hancock GE; Theuvenet WJ; Smith KA; Job CK; Roche PW; Molloy A; Burkhardt R; Barker J J Exp Med; 1991 Apr; 173(4):993-1006. PubMed ID: 2007862 [TBL] [Abstract][Full Text] [Related]
22. Suppression of Ia antigen expression on gamma interferon treated macrophages infected with Ehrlichia risticii. Messick JB; Rikihisa Y Vet Immunol Immunopathol; 1992 May; 32(3-4):225-41. PubMed ID: 1632064 [TBL] [Abstract][Full Text] [Related]
23. Effect of multiple interferon gamma injections on the disposal of Mycobacterium leprae. Kaplan G; Mathur NK; Job CK; Nath I; Cohn ZA Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8073-7. PubMed ID: 2510159 [TBL] [Abstract][Full Text] [Related]
24. Differential expression of Ia by murine keratinocytes and gut epithelium in response to recombinant gamma-interferon. Jun BD; Krueger GG; Roberts LK J Invest Dermatol; 1989 Jul; 93(1):33-9. PubMed ID: 2473137 [TBL] [Abstract][Full Text] [Related]
25. In vivo induction of Ia antigens on rat keratinocytes by gamma-interferon. Scheynius A; Johansson C; van der Meide PH Br J Dermatol; 1986 Nov; 115(5):543-9. PubMed ID: 2431705 [TBL] [Abstract][Full Text] [Related]
26. Lymphocytes and macrophages of the epidermis and dermis in lesional psoriatic skin, but not epidermal Langerhans cells, are depleted by treatment with cyclosporin A. Gupta AK; Baadsgaard O; Ellis CN; Voorhees JJ; Cooper KD Arch Dermatol Res; 1989; 281(4):219-26. PubMed ID: 2673064 [TBL] [Abstract][Full Text] [Related]
27. Effect of recombinant interferon gamma administration on lesional monocytes/macrophages in lepromatous leprosy patients. SivaSai KS; Prasad HK; Misra RS; Ramesh V; Wilfred D; Nath I Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):259-69. PubMed ID: 8396615 [TBL] [Abstract][Full Text] [Related]
28. The involvement of dendritic cells in the cutaneous lesions associated with tuberculoid and lepromatous leprosy. Collings LA; Waters MF; Poulter LW Clin Exp Immunol; 1985 Dec; 62(3):458-67. PubMed ID: 3910315 [TBL] [Abstract][Full Text] [Related]
29. Lack of expression of intercellular adhesion molecule ICAM-1 in lepromatous leprosy patients. Moncada B; Torres-Alvarez MB; Gonzalez-Amaro R; Fuentes-Ahumada C; Baranda L; Delgado SP; Garcia R Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):581-5. PubMed ID: 7512116 [TBL] [Abstract][Full Text] [Related]
30. Effects of recombinant gamma-interferon on HLA-DR and DQ expression by skin cells in short-term organ culture. Messadi DV; Pober JS; Murphy GF Lab Invest; 1988 Jan; 58(1):61-7. PubMed ID: 3121914 [TBL] [Abstract][Full Text] [Related]
31. Influences of gamma interferon on synovial fibroblast-like cells. Ia induction and inhibition of collagen synthesis. Amento EP; Bhan AK; McCullagh KG; Krane SM J Clin Invest; 1985 Aug; 76(2):837-48. PubMed ID: 2993365 [TBL] [Abstract][Full Text] [Related]
32. Correlation between keratinocyte expression of Ia and the intensity and duration of contact hypersensitivity responses in mice. Roberts LK; Spangrude GJ; Daynes RA; Krueger GG J Immunol; 1985 Nov; 135(5):2929-36. PubMed ID: 3862711 [TBL] [Abstract][Full Text] [Related]
33. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. Geppert TD; Lipsky PE J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267 [TBL] [Abstract][Full Text] [Related]
34. Effect of recombinant interferon-gamma on hydrogen peroxide-releasing capacity of monocyte-derived macrophages from patients with lepromatous leprosy. Kaplan G; Nathan CF; Gandhi R; Horwitz MA; Levis WR; Cohn ZA J Immunol; 1986 Aug; 137(3):983-7. PubMed ID: 3088117 [TBL] [Abstract][Full Text] [Related]
35. Antiproliferative effects of recombinant alpha- and gamma-interferons on cultured human keratinocytes. Nickoloff BJ; Basham TY; Merigan TC; Morhenn VB Lab Invest; 1984 Dec; 51(6):697-701. PubMed ID: 6209471 [TBL] [Abstract][Full Text] [Related]
36. Alterations induced in normal human skin by in vivo interferon-gamma. Barker JN; Allen MH; MacDonald DM Br J Dermatol; 1990 Apr; 122(4):451-8. PubMed ID: 2140046 [TBL] [Abstract][Full Text] [Related]
37. Density of epidermal Langerhans cells in psoriasis patients treated with an aromatic retinoid (RO 10-9359). An immunoperoxidase study using anti-T6 and anti-Ia monoclonal antibodies. Guzman de Fleury M; Tapia FJ; Soto J; Ghersi N; Convit J Histol Histopathol; 1986 Jul; 1(3):227-34. PubMed ID: 2856536 [TBL] [Abstract][Full Text] [Related]
38. Intravenous injection of interferon-gamma inhibits the proliferation of Listeria monocytogenes in the liver but not in the spleen and peritoneal cavity. Langermans JA; van der Hulst ME; Nibbering PH; van der Meide PH; van Furth R Immunology; 1992 Nov; 77(3):354-61. PubMed ID: 1478682 [TBL] [Abstract][Full Text] [Related]
39. Inability of recombinant interferon-gamma to activate the antibacterial activity of mouse peritoneal macrophages against Listeria monocytogenes and Salmonella typhimurium. van Dissel JT; Stikkelbroeck JJ; Michel BC; van den Barselaar MT; Leijh PC; van Furth R J Immunol; 1987 Sep; 139(5):1673-8. PubMed ID: 2957433 [TBL] [Abstract][Full Text] [Related]
40. Selective regulation of ICAM-1 and major histocompatibility complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells. Chang CH; Furue M; Tamaki K Eur J Immunol; 1994 Nov; 24(11):2889-95. PubMed ID: 7957579 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]